Skip navigation

Overcome Patient Affordability Barriers in an Evolving Managed Care Landscape

April 9-10, 2019
  • San Francisco, CA

Facilitating patient affordability and access to medication is one of the greatest ongoing areas of concern for pharma/biotech companies. While this is difficult in and of itself, companies must also navigate increased efforts from health plans to limit reimbursement of high cost therapeutics. Challenges continue to arise for manufacturers including accumulator programs, state-level copay legislation, formulary exclusions, high deductible plans, changes in benefit design, NDC blocks and step therapy programs.

CBI’s Formulary, Co-Pay and Access Summit provides a forum for industry to convene, benchmark and gain strategies to navigate new and impending access challenges within the value-based landscape while providing valuable patient services and support including coupons, co-pays and bridge programs.

Featured Content IncludeS:

  • Explore perspectives on accumulator adjustment programs and identify trends for the future
  • Demystify state-level copay card legislation and asses implications of future state-level regulations
  • Overcome challenges of high-deductible plans, copay caps and the evolving healthcare landscape
  • Gain insight on strategies for fast tracking prior authorization and copay assistance for specialty prescriptions
  • Gain insight on key stakeholder challenges to discover new methods for manufacturers to collaborate with payers, pharmacists and physicians to improve patient outcomes
  • Determine the impact of the growing biosimilars market on formulary placement across various care models including hospital, IDN and retail pharmacies
  • Field multiple offers at the same time including PNMT offers, Dollars off, Vouchers and PAP programs
  • Develop best practices to communicate with field reps when there are issues with co-pay cards

Previous Attendee Acclaim:

CBI does a great job focusing on relevant and timely market and customer topics. Their staff is professional and accommodating. As a speaker as well as a leader that sends staff to these conferences, I am consistently satisfied and impressed with the discussions and takeaways.

VP, Contracting & Channel Marketing, Bayer

I’m always so thankful for the perspectives shared at CBI conferences. I always take away great industry knowledge
and a deeper understanding of the triumphs and
struggles of my industry partners.

Access Services Manager, Fairview Specialty Pharmacy

Excellent appraisal of approaches and philosophies in
market access and engagement.

Senior Director, Quality Strategic Consumer Group, Janssen

A cost-effective way to learn from thought leaders, peers and vendors in a topic area of interest. Especially useful at the beginning of the year to set performance goals and think
of new approaches to explore during the year.

Assistant Director, Payer Marketing, Acorda Therapeutics

Formulary, Co-Pay and Access Summit

Overcome Patient Affordability Barriers in an Evolving Managed Care Landscape

Facilitating patient affordability and access to medication is one of the greatest ongoing areas of concern for pharma/biotech companies. While this is difficult in and of itself, companies must also navigate increased efforts from health plans to limit reimbursement of high cost therapeutics. Challenges continue to arise for manufacturers including accumulator programs, state-level copay legislation, formulary exclusions, high deductible plans, changes in benefit design, NDC blocks and step therapy programs.

CBI’s Formulary, Co-Pay and Access Summit provides a forum for industry to convene, benchmark and gain strategies to navigate new and impending access challenges within the value-based landscape while providing valuable patient services and support including coupons, co-pays and bridge programs.

Featured Content IncludeS:

  • Explore perspectives on accumulator adjustment programs and identify trends for the future
  • Demystify state-level copay card legislation and asses implications of future state-level regulations
  • Overcome challenges of high-deductible plans, copay caps and the evolving healthcare landscape
  • Gain insight on strategies for fast tracking prior authorization and copay assistance for specialty prescriptions
  • Gain insight on key stakeholder challenges to discover new methods for manufacturers to collaborate with payers, pharmacists and physicians to improve patient outcomes
  • Determine the impact of the growing biosimilars market on formulary placement across various care models including hospital, IDN and retail pharmacies
  • Field multiple offers at the same time including PNMT offers, Dollars off, Vouchers and PAP programs
  • Develop best practices to communicate with field reps when there are issues with co-pay cards

Previous Attendee Acclaim:

CBI does a great job focusing on relevant and timely market and customer topics. Their staff is professional and accommodating. As a speaker as well as a leader that sends staff to these conferences, I am consistently satisfied and impressed with the discussions and takeaways.

VP, Contracting & Channel Marketing, Bayer

I’m always so thankful for the perspectives shared at CBI conferences. I always take away great industry knowledge
and a deeper understanding of the triumphs and
struggles of my industry partners.

Access Services Manager, Fairview Specialty Pharmacy

Excellent appraisal of approaches and philosophies in
market access and engagement.

Senior Director, Quality Strategic Consumer Group, Janssen

A cost-effective way to learn from thought leaders, peers and vendors in a topic area of interest. Especially useful at the beginning of the year to set performance goals and think
of new approaches to explore during the year.

Assistant Director, Payer Marketing, Acorda Therapeutics